← Back to guidelines
Cardiology9 papers

Acute prosthetic mitral valve regurgitation

Last edited: 4/10/2026

Overview

Acute prosthetic mitral valve regurgitation is a serious complication that can occur after mitral valve surgery. It can lead to hemodynamic instability and requires prompt management.

Diagnosis

  • Diagnosis is typically made based on clinical presentation, echocardiography, and sometimes cardiac catheterization.
  • Echocardiography is crucial for assessing valve structure, function, and the severity of regurgitation.
  • Management

  • Management depends on the patient's hemodynamic stability and the underlying cause of regurgitation.
  • Hemodynamically unstable patients often require urgent surgical intervention, which may include valve repair or replacement.
  • Medical management may be used to optimize hemodynamics in stable patients while awaiting definitive treatment.
  • Key Recommendations

  • Robot-assisted mitral valve repair is comparable to conventional sternotomy and other minimally invasive approaches regarding rates of stroke, renal failure, reoperation for bleeding, and mortality 1.
  • Robot-assisted mitral valve repair may be superior to conventional sternotomy with reduced atrial fibrillation, shorter intensive care unit and hospital stays, less pain, and faster return to normal activities and physical functioning at 1 year 1.
  • Robot-assisted mitral valve repair is associated with longer cardiopulmonary, aortic cross-clamp, and procedure times compared with all other surgical approaches 1.
  • References

    1 Fatehi Hassanabad A, Nagase FNI, Basha AM, Hammal F, Menon D, Kent WDT et al.. A Systematic Review and Meta-Analysis of Robot-Assisted Mitral Valve Repair. Innovations (Philadelphia, Pa.) 2022. link

    Original source

    1. [1]
      A Systematic Review and Meta-Analysis of Robot-Assisted Mitral Valve Repair.Fatehi Hassanabad A, Nagase FNI, Basha AM, Hammal F, Menon D, Kent WDT et al. Innovations (Philadelphia, Pa.) (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG